Pharmaceutical Market Forecast Maintained Despite Wide-Ranging Price Cuts

BMI View: India's pharmaceutical pricing policy is unusually transparent for an emerging market. It also admirably attempts to balance the requirements of the key stakeholders: patients, manufacturers and regulators. Despite stringent medicine price controls in India, we continue to view the emerging market as very attractive to drugmakers, primarily due to the underlying fundamentals of high growth and the majority of spending being out-of-pocket.

To read the full article, please choose one of the following options: